DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Ioxilan

Ioxilan

  • MDCT and Contrast Media: What Are the Risks?

    MDCT and Contrast Media: What Are the Risks?

  • Pharmacologyonline 2: 727-753 (2010) Ewsletter Bradu and Rossini

    Pharmacologyonline 2: 727-753 (2010) Ewsletter Bradu and Rossini

  • Page 1 Note: Within Nine Months from the Publication of the Mention

    Page 1 Note: Within Nine Months from the Publication of the Mention

  • ACR Manual on Contrast Media

    ACR Manual on Contrast Media

  • ACR Manual on Contrast Media – Version 9, 2013 Table of Contents / I

    ACR Manual on Contrast Media – Version 9, 2013 Table of Contents / I

  • Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set

    Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set

  • Injection of Contrast Media V7 – 2010 13 5

    Injection of Contrast Media V7 – 2010 13 5

  • The Risk of Contrast Media-Induced Ventricular Fibrillation Is Low in Canine Coronary Arteriography with Ioxilan

    The Risk of Contrast Media-Induced Ventricular Fibrillation Is Low in Canine Coronary Arteriography with Ioxilan

  • Active Moiety Name FDA Established Pharmacologic Class (EPC) Text

    Active Moiety Name FDA Established Pharmacologic Class (EPC) Text

  • Premedication for Contrast Medium Allergies Factfinder

    Premedication for Contrast Medium Allergies Factfinder

  • Pharmacy Data Management Drug Exception List

    Pharmacy Data Management Drug Exception List

  • FDA Listing of Established Pharmacologic Class Text Phrases January 2021

    FDA Listing of Established Pharmacologic Class Text Phrases January 2021

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

  • Orange Book Cumulative Supplement 7 July 2016

    Orange Book Cumulative Supplement 7 July 2016

  • Manual on Contrast Media Version 7 2010

    Manual on Contrast Media Version 7 2010

  • A Machine-Learning Approach to Measuring Tumor Ph Using MRI

    A Machine-Learning Approach to Measuring Tumor Ph Using MRI

  • WO 2017/222911 A1 (.Pdf)

    WO 2017/222911 A1 (.Pdf)

  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

    Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

Top View
  • Contrast-Induced Encephalopathy Following Coronary Angioplasty with Iopromide
  • ACR Manual on Contrast Media (2020)
  • Revised References to Heavy Metals <231>
  • Atc Index 2010
  • Delirious After Undergoing Workup for Stroke Veeraraghavan Iyer, MBBS, MD, and Douglas Opler, MD
  • )&F1y3x PHARMACEUTICAL APPENDIX to THE
  • (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
  • ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
  • (12) United States Patent (10) Patent No.: US 8,518,373 B2 Aimeet Al
  • ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
  • XENETIX Mono
  • Total Organic Halogen Formation in the Presence Of
  • (12) Patent (19) Australian Patent Office
  • Version 10.3
  • Wo 2007/044693 A2
  • United States Patent [19] [11] Patent Number: 5,840,967 Gulbrandsen Et Al
  • Pharmacology, Part 5: CT and MRI Contrast Media
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances


© 2024 Docslib.org    Feedback